While victims filing claims over Actos bladder cancer in a federal court likely won’t see trials start until 2014, another set of cases filed in California is scheduled to start this month.
Fortunately, the earlier trials could set a precedent for the rest or even pressure drug maker Takeda Pharmaceuticals into an Actos settlement, experts say.
Beginning in 2011, health experts with the FDA, European Medicines Agency and Health Canada warned that extended use of Actos could relate to increased risks of bladder cancer.
After studies showed the risk could be as much as 40% higher, both France and Germany banned new Actos prescriptions.
Once the best selling diabetes drug in the world, Actos use has fallen sharply in recent years due to the warnings, competition from generics, and news of thousands of patients filing an Actos lawsuit for bladder cancer.
According to a Bloomberg News report, Takeda faces as many as 3,000 lawsuits over Actos bladder cancer.* Over 1,200 of these were filed in a special federal multi-district litigation court in Louisiana, while others were filed in a California state court.
Bloomberg reported that jury selection was set to start this month in several cases in the California court where the judge deemed expedited litigation necessary due to victims’ declining health.
DrugRisk will monitor the outcome of these trials to provide the latest news. While lawyers are still helping those victims of Actos bladder cancer who have not filed a claim do so, the time to take action is limited.
If you or a loved one were diagnosed with bladder cancer after taking Actos, it is important to speak with a lawyer about your legal rights as soon as possible.
Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Actos, or to speak with a lawyer.